Farmson Basic Drugs Private Ltd, based in India, is a pharmaceutical company that stands out with its certifications from EDQM and WHO-GMP.
One of their notable products is ACETAMINOPHEN USP, with a corresponding US DMF Number 35240.
Remarkably, this DMF maintains an Active status since its submission on February 28, 2021, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of July 28, 2025, and payment made on February 19, 2021, indicating their dedication to facilitating drug approvals, Categorized as Type II